William Shell, CEO & Chief Scientific Officer, 10% Owner at Targeted Medical Pharma, Inc. (TRGM), sold 8,344,748 shares at $0.84 ($2K) on 2013-09-13, disclosed to the SEC on 2013-09-20.
Open-market sale of $2k TRGM by CEO & Chief Scientific Officer, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 8,342,748 | $0 | 0.0% |
| 2 | $0.84 | 2,000 | $2K | 100.0% |
| Total | $0.00 avg | 8,344,748 | $2K | 100% |
| Filing → |
| TRGM | SELL | 2014-04-10 | $90K | — | Filing → |
| PrivateTargeted Medical Pharma, Inc. | BUY | 2013-07-23 | $269K | — | Filing → |